Categories Technology, U.S. Markets News

U.S. and China in talks to remove restrictions on ZTE

The U.S. and China are said to be nearing a deal that could see the removal of the restrictions imposed on Chinese firm ZTE Corp. The deal, which is not yet official, could also include China’s removal of tariffs on U.S. agricultural products. On Monday, President Trump tweeted that the potential deal with China will benefit U.S. farmers.

Last month, the U.S. government banned all supplies from American companies to ZTE as a penalty for violations of trade agreements. This almost put the Chinese company out of business and increased the trade war tension between the U.S. and China. ZTE will now have to simply pay hefty fines and make changes in its management team. President Trump had indicated that he would help ZTE get back into business as the ban had affected a lot of jobs in China.

US-China talks on ZTE ban

This decision has not gone down well with several prominent people in political and industrial circles who believe that the U.S. government was allowing China to coax it into making a decision that was unfavorable for America. Senator Marco Rubio openly criticized the government for withdrawing from its previous firm position on ZTE and went on to state that minor penalties would not prevent ZTE from repeating past infractions as was seen in prior instances.

China is said to have already slashed tariffs on car imports bringing a relief to trade tensions between the two companies

China is said to have already slashed tariffs on car imports bringing a relief to trade tensions between the two companies. However, several people are unhappy that the U.S. is not fiercely tackling China’s unsporting trade practices. The ZTE deal is not yet confirmed but will be part of the efforts to find a middle ground with China on the ongoing trade issues.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top